1. Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
   Shangyu Chai et al, 2022, Frontiers in Endocrinology CrossRef
2. Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis
   SuA Oh et al, 2022, Diabetes and Vascular Disease Research CrossRef
3. Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis
   Shangyu Chai et al, 2022, Frontiers in Endocrinology CrossRef
4. Effect of DPP-IV Inhibitors on Glycemic Variability in Patients with T2DM: A Systematic Review and Meta-Analysis
   Subin Lee et al, 2019, Scientific Reports CrossRef